Zürich, Switzerland

Pietro Gozzoli

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Pietro Gozzoli

Introduction

Pietro Gozzoli is a notable inventor based in Zürich, Switzerland. He has made significant contributions to the field of medical devices, particularly in the area of cardiac health. His innovative work focuses on developing solutions that enhance patient care and improve medical procedures.

Latest Patents

Gozzoli holds a patent for a left atrial appendage occlusion device. This device is designed to occlude the left atrial appendage (LAA) and includes a compliant balloon that defines a fluid-tight balloon chamber. An actuating shaft is partially contained within the balloon chamber, allowing for the adjustment of the distance between the distal and proximal end portions of the balloon. The device features a locking mechanism that can switch between locked and unlocked states, ensuring that the distance set by the actuating shaft is maintained when locked. Additionally, the occlusion device is designed to create a fluid flow path along a portion of the actuating shaft, with a valve that selectively allows or blocks fluid flow between the fluid flow path and the balloon chamber.

Career Highlights

Gozzoli is affiliated with the Universität Zürich, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve medical outcomes for patients with specific cardiac conditions.

Collaborations

He collaborates with esteemed colleagues, including Andrea Guidotti and Boaz Harari, who contribute to the innovative projects at the university.

Conclusion

Pietro Gozzoli's contributions to the field of medical devices exemplify the impact of innovation in healthcare. His patented occlusion device represents a significant advancement in cardiac treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…